Draw
Home Products

AG00408H

890842-28-1 | GSK 650394

890842-28-1
AG00408H
sdsSDS
sdsCOA

Price

$0.00

WARNING This product is not for human or veterinary use.
Request For Quotation
CAS Number 890842-28-1
Catalog Number AG00408H(AGN-PC-04VY54)
Chemical Name GSK 650394
IUPAC Name 2-cyclopentyl-4-(5-phenyl-1H-pyrrolo[2,3-b]pyridin-3-yl)benzoic acid
InChI InChI=1S/C25H22N2O2/c28-25(29)20-11-10-18(12-21(20)17-8-4-5-9-17)23-15-27-24-22(23)13-19(14-26-24)16-6-2-1-3-7-16/h1-3,6-7,10-15,17H,4-5,8-9H2,(H,26,27)(H,28,29)
InChI Key WVSBGSNVCDAMCF-UHFFFAOYSA-N
MDL Number MFCD12828779
Molecular Formula C25H22N2O2
Molecular Weight 382.4544
SMILES O=C(O)C1=CC=C(C2=CNC3=NC=C(C4=CC=CC=C4)C=C32)C=C1C5CCCC5
UNII 56887611DJ
Synonyms
GSK 650394, GSK-650394, GSK650394, GSK 650394, 890842-28-1, GSK650394, GSK-650394, 2-cyclopentyl-4-(5-phenyl-1H-pyrrolo[2,3-b]pyridin-3-yl)benzoic acid, UNII-56887611DJ, CHEMBL558642, AK170277, 56887611DJ, 2-Cyclopentyl-4-(5-phenyl-1H-pyrrolo[2,3-b]pyridin-3-yl-benzoic acid, DXV, MLS006010262, GTPL8040, SCHEMBL3767908, CHEBI:95066, CTK8F0693, KS-00000SYH, AOB4299, DTXSID60237532, SYN5178, HMS2043A20, HMS3653A19, HMS3677P22, BCP08392, EX-A2233, 2441AH, BDBM50296011, MFCD12828779, s7209, ZINC43015507, AKOS024457693, Benzoic acid, 2-cyclopentyl-4-(5-phenyl-1H-pyrrolo(2,3-b)pyridin-3-yl)-, API0008785, CS-1853, NCGC00250410-01, 4CA-1390, AS-16796, BC600728, DA-01722, HY-15192, QC-10459, SMR004701335, RT-013123, B1051, FT-0742103, SW219479-1, J3.540.996C, BRD-K14991967-001-01-8, 2-Cyclopentyl-4-(5-phenyl-1H-pyrrolo[2,3-b]pyridin-3-yl)-benzoic acid, D0F3FC, WVSBGSNVCDAMCF-UHFFFAOYSA-N, C25H22N2O2, A13309, C532254, SGK-1 inhibitor (prostate cancer), GlaxoSmithKline,

Product Recommendations

    CERTIFICATE OF ANALYSIS
    Chemical Name: Batch Number:
    Chemical Structure: CAS Registry No:
    		Product ID:
    Manufacture Date:
    Storage Temperature:
    Formula:
    Molecular Weight:
    Quantity:
    Analysis Data:
    Test: Result:
    Conclusion: The above product meets the specifications of Angene.
    Analyst:Chase
    Date:
    Reviewed by:Jessie
    Date:
    Angene International Limited